logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Hematologic Malignancies Acute Leukemias Elihu H Estey Sh Faderl

  • SKU: BELL-1184466
Hematologic Malignancies Acute Leukemias Elihu H Estey Sh Faderl
$ 31.00 $ 45.00 (-31%)

4.3

38 reviews

Hematologic Malignancies Acute Leukemias Elihu H Estey Sh Faderl instant download after payment.

Publisher: Springer
File Extension: PDF
File size: 13.56 MB
Pages: 301
Author: Elihu H. Estey, S.H. Faderl, H.M. Kantarjian
ISBN: 9783540723028, 3540723021
Language: English
Year: 2008

Product desciption

Hematologic Malignancies Acute Leukemias Elihu H Estey Sh Faderl by Elihu H. Estey, S.h. Faderl, H.m. Kantarjian 9783540723028, 3540723021 instant download after payment.

Better therapy of acute leukemias depends ultimately on better understanding of the distinction between leukemic and normal progenitor cells. Thus, several chapters in this volume describe current knowledge of acute leukemia biology and discuss new classification systems that have arisen consequent to emerging insights into pathogenesis. Treatment has also improved for particular types of acute leukemia. Given our intention that the book be useful to clinicians, we pay particular attention to these advances, to management of acute leukemia in general, and to development of new therapies.

Related Products